NDC 76233-072
Ganciclovir
Ganciclovir Sodium
Ganciclovir is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Laboratorio Reig Jofre, S.a.. The primary component is Ganciclovir Sodium.
| Product ID | 76233-072_1187c030-f17b-46ad-8be6-69f0bea3ff41 |
| NDC | 76233-072 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ganciclovir |
| Generic Name | Ganciclovir Sodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-08-25 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207815 |
| Labeler Name | Laboratorio Reig Jofre, S.A. |
| Substance Name | GANCICLOVIR SODIUM |
| Active Ingredient Strength | 500 mg/10mL |
| Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |